ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
Dow Jones
39,065.26
-1.53%
US Dollar vs MXN
16.72749
0.38%
Brent Oil
81.335
-0.24%
Bitcoin
67,499.37
-2.32%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Dyne Therapeutics Inc (DYN)

  7. Dyne Therapeutics Inc (DYN) Noticias

DYN Dyne Therapeutics Inc

31.25
-0.28 (-0.89%)
Fuera de horario
Última actualización: 15:00:42
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Dyne Therapeutics Inc DYN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.28 -0.89% 31.25 15:00:42
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
31.95 30.93 32.0599 31.33 31.53
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/5/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/5/202406:59EDGAR2Form 8-K - Current report
21/5/202419:39GLOBEDyne Therapeutics Announces Pricing of $325.5 Million Public..
20/5/202417:00EDGAR2Form 144 - Report of proposed sale of securities
20/5/202415:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/5/202415:01GLOBEDyne Therapeutics Announces Proposed Public Offering of..
20/5/202406:37EDGAR2Form 8-K - Current report
20/5/202405:30GLOBEDyne Therapeutics Announces New Clinical Data from ACHIEVE..
19/5/202407:00GLOBEDyne Therapeutics to Host Virtual Investor Event to Review..
17/5/202420:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:26EDGAR2Form 144 - Report of proposed sale of securities
16/5/202415:23EDGAR2Form 144 - Report of proposed sale of securities
16/5/202415:18EDGAR2Form 144 - Report of proposed sale of securities
02/5/202415:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
27/3/202415:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
27/3/202407:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
25/3/202406:30GLOBEDyne Therapeutics Announces CEO Transition
13/3/202406:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
11/3/202416:36EDGAR2Form 144 - Report of proposed sale of securities
11/3/202416:35EDGAR2Form 144 - Report of proposed sale of securities
11/3/202416:35EDGAR2Form 144 - Report of proposed sale of securities
08/3/202415:53EDGAR2Form 144 - Report of proposed sale of securities
07/3/202419:19EDGAR2Form 144 - Report of proposed sale of securities
07/3/202419:18EDGAR2Form 144 - Report of proposed sale of securities
07/3/202419:16EDGAR2Form 144 - Report of proposed sale of securities
05/3/202407:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
05/3/202406:41EDGAR2Form 8-K - Current report
05/3/202406:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202406:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202406:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
01/3/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:33EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:08EDGAR2Form 144 - Report of proposed sale of securities
29/2/202418:49EDGAR2Form 144 - Report of proposed sale of securities
23/2/202416:23EDGAR2Form 144 - Report of proposed sale of securities
14/2/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:15GLOBEDyne Therapeutics Announces Upcoming Presentations on..
14/2/202407:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202416:40EDGAR2Form 144 - Report of proposed sale of securities
01/2/202406:30GLOBEDyne Therapeutics to Present at February Investor..
26/1/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202418:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202418:46EDGAR2Form 144 - Report of proposed sale of securities
11/1/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202415:05GLOBEDyne Therapeutics Announces Closing of Public Offering of..
05/1/202415:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202407:02EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
DYN
Dyne Therapeutics
EU
BE6211343452
Bpost banque 1.5% until ...
COIN
ULGGBP
EU
BE0002853340
Belgium French Community...
BIT
P1XGO1
NLBNPIT1XGO1 20240920 32...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados